Steven R. Feldman, MD, PhD | Wake ...

Dr. Steven Feldman, MD, PhD

Claim this profile

Wake Forest University Health Sciences Department of Dermatology

Studies Psoriasis
Studies Medication Adherence
10 reported clinical trials
20 drugs studied

Affiliated Hospitals

Image of trial facility.
Wake Forest University Health Sciences, Department Of Dermatology
Image of trial facility.
Wake Forest Health Sciences Dermatology

Clinical Trials Steven Feldman, MD, PhD is currently running

Image of trial facility.

Topical Treatment

for Eczema

Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.
Recruiting1 award N/A
Image of trial facility.

Topical Acne Medications

for Acne

Acne is a chronic condition that typically requires the use of multiple medications.1 Medication adherence is especially challenging for patients with chronic diseases and often decreases over time, especially for those using topical medications.1 Nonadherence can result in multiple negative effects including treatment failure, increased healthcare costs, and decreased quality of life. Primary nonadherence refers to problems acquiring and starting treatment. Challenges to this form of nonadherence include a lack of knowledge, misunderstanding of usage, poor communication with provider, increased cost, and fear of side effects.2 Secondary nonadherence refers to when the patient does not use the medication as prescribed. Hurdles to secondary nonadherence include delayed results, increased complexity of treatment plan, adverse effects, busy lifestyle, and inconvenience.2
Recruiting1 award Phase < 14 criteria

More about Steven Feldman, MD, PhD

Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Steven Feldman, MD, PhD has experience with
  • Triamcinolone Cream
  • Normal Education Material
  • Vignette
  • Transcutaneous Electrical Nerve Stimulation (TENS) Therapy
  • Use Of Topical Moisturizer
  • Ivermectin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Steven Feldman, MD, PhD specialize in?
Is Steven Feldman, MD, PhD currently recruiting for clinical trials?
Are there any treatments that Steven Feldman, MD, PhD has studied deeply?
What is the best way to schedule an appointment with Steven Feldman, MD, PhD?
What is the office address of Steven Feldman, MD, PhD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security